ctdna kras mutation levels and outcomes in non-resectable pancreatic cancer
Published 9 years ago • 297 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:41
improving outcomes in kras-mutant pancreatic cancer
-
0:51
personalized treatment approaches for patients with kras-mutant pancreatic cancer
-
5:17
mutant p53 and oncogenic kras drive metastasis in pancreatic cancer
-
5:10
association between kras mutation, detected in pancreatic cyst fluid...
-
0:47
artemis-pc: personalized panel for circulating tumor dna in pancreatic cancer
-
7:57
case 3: kras-mutated metastatic colon cancer
-
1:17
codebreak100: assessing sotorasib in patients with kras p.g12c-mutant pancreatic cancer
-
45:20
voice of pancreatic cancer podcast - targeting the kras mutation for more effective cancer treatment
-
1:14
kras mutations and cancer
-
1:45
the future of precision oncology in pancreatic cancer
-
0:59
how physicians can detect ctdna in melanoma
-
0:36
advances in the treatment of pancreatic cancer
-
10:37
understanding pancreatic cancer
-
1:43
survival differences in kras/braf mutations in mcrc
-
3:46
targeting colorectal cancer: kras and nras mutations
-
2:42
assessing the heterogeneity of kras-mutant pancreatic adenocarcinomas
-
1:10
dr. ocean discusses the use of ctdna in pancreatic cancer
-
6:30
testing for kras mutations in nsclc
-
1:56
dr. peeters on kras/nras mutations in mcrc